Changeflow GovPing Healthcare & Life Sciences HIIT Versus Moderate Continuous Training in ACHD
Routine Notice Added Final

HIIT Versus Moderate Continuous Training in ACHD

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

A single-center randomized controlled trial registered on ClinicalTrials.gov (NCT07546227) will evaluate the effect of interval training versus moderate continuous exercise training compared to usual care (no training) on exercise capacity in patients with adult congenital heart disease (CHD). The primary endpoint is peak VO2; secondary aims include assessing safety of exercise training in CHD, evaluating effects on cardiac structure and function, and measuring quality of life and long-term physical activity. Participants receive an exercise intervention (interval training or moderate continuous training) or no exercise control.

“This study is a single center randomized controlled trial evaluating the effect of an exercise training intervention (interval training or moderate continuous training) compared to usual care (no training) on exercise capacity in patients with congenital heart disease (CHD).”

NIH , verbatim from source
Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ClinicalTrials.gov Studies for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 627 changes logged to date.

What changed

This document registers a new clinical trial (NCT07546227) on ClinicalTrials.gov, establishing the study parameters for a single-center randomized controlled trial in adults with congenital heart disease. The trial will randomize participants to interval training, moderate continuous training, or a control group receiving usual care with no exercise intervention. For healthcare providers and clinical investigators, this registry entry establishes the study's existence and scope, including primary and secondary endpoints, intervention types, and anticipated enrollment population. The study is registered with an anticipated start date and represents a formal clinical research protocol rather than a binding regulatory requirement.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

HIIT Vereus Moderate Continuous Training in ACHD

N/A NCT07546227 Kind: NA Apr 22, 2026

Abstract

This study is a single center randomized controlled trial evaluating the effect of an exercise training intervention (interval training or moderate continuous training) compared to usual care (no training) on exercise capacity in patients with congenital heart disease (CHD).

Our primary aim is to determine the impact of interval training (IT) compared to moderate continuous exercise training (MCT) versus controls (no exercise) on exercise capacity as measured by peak VO2. Secondary aims are to: 1) assess the safety of exercise training in CHD, 2) evaluate the effect of exercise training on cardiac structure and function and 3) assess the effects of exercise training on quality of life and long-term physical activity.

Conditions: Adult Congenital Heart Disease

Interventions: Exercise Intervention

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 22nd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Healthcare providers Patients
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Exercise intervention research
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Pharmaceuticals Public Health

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!